A cost-effectiveness analysis of genetic testing of the DRD2 Taq1A polymorphism to aid treatment choice for smoking cessation.

A cost-effectiveness analysis of genetic testing of the DRD2 Taq1A polymorphism to aid treatment choice for smoking cessation.

We conducted a cost-effectiveness analysis of genetic testing for smoking cessation, based on data available from the published pharmacogenetic studies of nicotine replacement therapy and bupropion, and a previous cost-effectiveness analysis of smoking cessation treatments. We use multiparameter evi...

Full description

Bibliographic Details
Main Authors:	Welton, N, Johnstone, E, David, S, Munafò, MR
Format:	Journal article
Language:	English
Published:	2008

Similar Items

Lack of association of DRD2 rs1800497 (Taq1A) polymorphism with smoking cessation in a nicotine replacement therapy randomized trial.
by: Munafò, MR, et al.
Published: (2009)

Lack of association of DRD2 rs1800497 (Taq1A) polymorphism with smoking cessation in a nicotine replacement therapy randomized trial
by: Munafo, M, et al.
Published: (2009)

Smoking cessation, weight gain, and DRD4 -521 genotype
by: Munafò, MR, et al.
Published: (2006)

Smoking status moderates the association of the dopamine D4 receptor (DRD4) gene VNTR polymorphism with selective processing of smoking-related cues.
by: Munafò, MR, et al.
Published: (2008)

Genetic variation in the dopamine D4 receptor (DRD4) gene and smoking cessation: follow-up of a randomised clinical trial of transdermal nicotine patch.
by: David, S, et al.
Published: (2008)

Association of the DRD2 gene Taq1A polymorphism and alcoholism: a meta-analysis of case-control studies and evidence of publication bias.
by: Munafo, MR, et al.
Published: (2007)

Effects of dopamine D2 receptor gene polymorphisms on smoking cessation: Abstinence and withdrawal symptoms
by: Munafo, MR, et al.
Published: (2007)

The dopamine D2 receptor C32806T polymorphism (DRD2 Taq1A RFLP) exhibits no association with smoking behaviour in a healthy UK population.
by: Johnstone, E, et al.
Published: (2004)

Lack of association of OPRM1 genotype and smoking cessation.
by: Munafò, MR, et al.
Published: (2013)

Effectiveness and cost-effectiveness of computer and other electronic aids for smoking cessation: a systematic review and network meta-analysis.
by: Chen, Y, et al.
Published: (2012)

Association between nicotinic acetylcholine receptor single nucleotide polymorphisms and smoking cessation.
by: Spruell, T, et al.
Published: (2012)

Effectiveness and cost-effectiveness of computer and other electronic aids for smoking cessation: a systematic review and network meta-analysis
by: Aveyard, P, et al.
Published: (2012)

Association of the mu-opioid receptor gene with smoking cessation.
by: Munafò, MR, et al.
Published: (2007)

Association of COMT Val108/158Met genotype with smoking cessation.
by: Munafò, MR, et al.
Published: (2008)

Interventions for smoking cessation in hospitalised patients.
by: Rigotti, N, et al.
Published: (2003)

Interventions for smoking cessation in hospitalised patients.
by: Rigotti, N, et al.
Published: (2001)

Interventions for smoking cessation in hospitalised patients.
by: Rigotti, N, et al.
Published: (2003)

Interventions for smoking cessation in hospitalised patients
by: Rigotti, N, et al.
Published: (2012)

CHRNA3 rs1051730 genotype and short-term smoking cessation.
by: Munafò, MR, et al.
Published: (2011)

The Association of DRD2 Gene TaqI Polymorphism with Attention Deficit Hyperactivity Disorder a Population Sample of Iranian Azeri-children
by: Leila Mehdizadeh Fanid, et al.
Published: (2016-05-01)

Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers
by: Schuit, E, et al.
Published: (2017)

Smoking cessation pharmacotherapy based on genetically-informed biomarkers: what is the evidence?
by: Panagiotou, OA, et al.
Published: (2019)

Pharmacogenetics of smoking cessation in general practice: results from the patch II and patch in practice trials.
by: David, S, et al.
Published: (2011)

Genetic variation in the serotonin pathway and smoking cessation with nicotine replacement therapy: new data from the Patch in Practice trial and pooled analyses.
by: David, S, et al.
Published: (2008)

ANKK1/DRD2 gene Taq1A polymorphism (rs1800497) as a possible genetic marker of food-addiction-related eating disturbances in overweight patients
by: A. A. Kibitov, et al.
Published: (2020-04-01)

Smoking cessation interventions for hospitalized smokers: a systematic review.
by: Rigotti, N, et al.
Published: (2008)

Investigating subgroups in smoking cessation treatment response: Response to Perkins
by: Munafo, MR, et al.
Published: (2004)

Genes and cigarette smoking.
by: Munafò, MR, et al.
Published: (2008)

Weekly versus basic smoking cessation support in primary care: a randomised controlled trial.
by: Aveyard, P, et al.
Published: (2007)

Association of COMT Val108/158Met genotype with smoking cessation in a nicotine replacement therapy randomized trial.
by: Johnstone, E, et al.
Published: (2007)

Genome-wide association for smoking cessation success: participants in the Patch in Practice trial of nicotine replacement.
by: Uhl, G, et al.
Published: (2010)

Biomedical risk assessment as an aid for smoking cessation
by: Clair, C, et al.
Published: (2019)

Costs of the Smoking Cessation Program in Brazil
by: Andréa Cristina Rosa Mendes, et al.

Pharmacogenomics of nicotine dependence and impact on smoking cessation
by: Johnstone, E, et al.
Published: (2007)

Dopamine DRD2 and DRD3 Polymorphisms Involvement in Nicotine Dependence in Patients with Treatment-Resistant Mental Disorders
by: Antonio del Casale, et al.
Published: (2022-04-01)

No association between functional catechol O-methyl transferase 1947A>G polymorphism and smoking initiation, persistent smoking or smoking cessation.
by: David, S, et al.
Published: (2002)

Association of DRD2/ANKK1 Taq1A polymorphism with depression in an open 45–64 year-old male population (international epidemiological HAPIEE and WHO MONICA programs)
by: V. V. Gafarov, et al.
Published: (2019-06-01)

Smoking Genes: A Case–Control Study of Dopamine Transporter Gene (<i>SLC6A3</i>) and Dopamine Receptor Genes (<i>DRD1</i>, <i>DRD2</i> and <i>DRD3</i>) Polymorphisms and Smoking Behaviour in a Malay Male Cohort
by: Abu Bakar Ruzilawati, et al.
Published: (2020-12-01)

Interaction Effects of DRD2 Genetic Polymorphism and Interpersonal Stress on Problematic Gaming in College Students
by: Esther Kim, et al.
Published: (2022-02-01)

Genetic polymorphisms in dopamine-related genes and smoking cessation in women: a prospective cohort study
by: Srinouanprachan Sengkeo, et al.
Published: (2007-04-01)